GlassScriptPhysician profile
Michael Sylvester
NPI 1245767383
$5,248.41
in general payments reported to CMS, 2019-2025
15 companies · $3,404 in 2025
The $3,404 reported for 2025 was more than what 86% of Otolaryngic Allergy providers received nationally (typical 2025 total: $449).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,844 · 2025: $3,404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,833 · Food and Beverage: $2,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,833.04 |
| Food and Beverage | $2,415.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,890.64 | 2024-2025 | Scopis Ent, Audion Et Dilation System, Clarifix Cryotherapy Device |
| Integra Lifesciences Corporation | $1,611.31 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Genzyme Corporation | $713.44 | 2024-2025 | |
| Neurent Medical Limited | $276.30 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Glaxosmithkline, LLC. | $211.61 | 2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $157.78 | 2024-2025 | Dupixent |
| Inspire Medical Systems, INC. | $97.37 | 2024-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $94.32 | 2025 | Tezspire |
| Amgen INC. | $39.59 | 2025 | Tezspire |
| Medtronic, INC. | $37.68 | 2024-2025 | Stealthstation S8 Platform |
| Optinose US, INC. | $29.06 | 2025 | |
| Aerin Medical INC. | $28.89 | 2024 | |
| Lilly USA, LLC | $22.98 | 2025 | Zepbound |
| Paratek Pharmaceuticals, INC. | $21.84 | 2025 | Xhance |
| Phathom Pharmaceuticals, INC. | $15.60 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sylvester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.